Ayala Pharmaceuticals logo

Ayala Pharmaceuticals AYLA

$ 0.5 0.0%

Annual report 2022
added 03-31-2023

report update icon

Country

israelIsrael

IPO year

2020

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

CEO

Dr. Roni Mamluk

Employees in the company

31

Shares

15.4 M

Market Cap[1]

$ 7.46 M

EBITDA (LTM)

$ -37 M

P/E (LTM)

-0.2

P/S (LTM)

6.16

EPS (LTM)

-2.54

Other stocks of industry "Biotechnology"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.